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Abstract
Background: Oncoprotein Tax, encoded by the human T-cell leukemia virus type 1 (HTLV1), persistently induces
NF-B activation, which contributes to HTLV1-mediated T-cell transformation. Recent studies suggest that the
signaling function of Tax requires its ubiquitination, although how the Tax ubiquitination is regulated remains
unclear.
Results: We show here that the deubiquitinase CYLD physically interacts with Tax and negatively regulates the
ubiquitination of this viral protein. This function of CYLD is associated with inhibition of Tax-mediated activation of
IKK although not that of Tak1. Interestingly, CYLD undergoes constitutive phosphorylation in HTLV1-transformed
T cells, a mechanism known to inactivate the catalytic activity of CYLD. Consistently, a phospho-mimetic CYLD
mutant fails to inhibit Tax ubiquitination.
Conclusion: These findings suggest that CYLD negatively regulates the signaling function of Tax through inhibition
of Tax ubiquitination. Conversely, induction of CYLD phosphorylation may serve as a mechanism by which HTLV1
overrides the inhibitory function of CYLD, leading to the persistent activation of NF-B.
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Background
Human T-cell leukemia virus type 1 (HTLV1) is an onco-
genic retrovirus that is etiologically associated with a
human acute T-cell malignancy termed adult T-cell leu-
kemia (ATL) [1-3]. HTLV1 genome encodes a 40-kD
protein that not only regulates viral gene expression but
also induces various cellular genes contributing to
HTLV1-mediated T-cell transformation [4]. Tax modu-
lates the activity of different cellular transcription factors,
most importantly NF-B, a family of enhancer-binding
proteins regulating cell growth and survival [5]. The
activity of NF-B is normally subject to tight regulation
by a cytoplasmic inhibitor, IB. In response to cellular
stimuli, IB is phosphorylated by a specific IBk i n a s e
(IKK) and targeted for ubiquitination and proteasomal
degradation, resulting in nuclear translocation of active
NF-B [6,7]. Under normal conditions, the activation of
IKK and NF-B occurs transiently, which assures that
the expression of NF-B target genes is induced tempo-
rally. However, in HTLV1-infected T cells, Tax persis-
tently stimulates the activity of IKK, leading to
constitutive nuclear expression of NF-B [8-10]. Strong
evidence suggests that deregulated NF-B activation has
a central role in HTLV1-mediated T-cell transformation
[5,11,12].
We and others have previously shown that Tax physi-
cally interacts with the IKK complex via the IKK regula-
tory subunit IKKg (also called NEMO), and this molecular
interaction is critical for Tax-mediated IKK activation
[13-15]. More recent work suggests that the signaling
function of Tax requires its ubiquitination [16-18].
Although ubiquitination is traditionally viewed as a
mechanism that mediates protein degradation in the pro-
teasome, it is now clear that specific types of ubiquitina-
tion also facilitate the activation of protein kinases,
including IKK [19]. In particular, lysine 63 (K63)-linked
polyubiquitin chains may serve as a platform that helps
recruit and activate IKK and its activating kinase, Tak1.
Like phosphorylation, ubiquitination is a reversible reac-
tion, which is counter-regulated by ubiquitinating enzymes
and deubiquitinases (DUBs) [20]. A DUB, CYLD, has been
* Correspondence: ssun@mdanderson.org
† Contributed equally
3Department of Immunology, The University of Texas MD Anderson Cancer
Center, 7455 Fannin Street, Box 902, Houston TX 77030, USA
Full list of author information is available at the end of the article
Wu et al. Cell & Bioscience 2011, 1:27
http://www.cellandbioscience.com/content/1/1/27 Cell & Bioscience
© 2011 Wu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.shown to preferentially deconjugate K63-linked ubiquitin
chains [21] and implicated as a negative regulator of IKK/
NF-B signaling. CYLD has constitutive DUB activity, but
its activity can be rapidly inactivated via its phosphoryla-
tion in response to NF-B stimuli [22].
Tax undergos K63 type of ubiquitination, which is criti-
cal for activation of NF-B [23]. However, how the ubi-
quitination of Tax is regulated remains unclear. In the
present study, we have shown that Tax forms a complex
with CYLD, in which CYLD strongly inhibits the ubiqui-
tination and signaling function of Tax. Interestingly, in a
large panel of HTLV1-transformed T-cell lines, CYLD is
constitutively phosphorylated. These findings not only
establish CYLD as a negative regulator of Tax ubiquitina-
tion but also suggest a mutual regulatory mechanism in
which HTLV1 stimulates CYLD phosphorylation and
functional inactivation.
Results
Tax physically interacts with CYLD
A prior study suggests that Tax is preferentially conju-
gated with K63-linked ubiquitin chains [23]. Since CYLD
is a K63-specific DUB, we examined whether the ubiquiti-
nation of Tax is negatively regulated by CYLD. We first
examined the potential physical interaction between Tax
and CYLD. In HTLV1-transformed T cells, Tax was read-
ily co-precipitated with CYLD, suggesting that CYLD is
present in the Tax complex (Figure 1A). The Tax/CYLD
physical association is specific, since a pre-immune serum
did not precipitate Tax (Figure 1A). Furthermore, Tax also
interacted with CYLD in transiently transfected cells
(Figure 1B). Interestingly, the Tax/CYLD interaction
appeared to be enhanced by the IKK regulatory subunit,
IKKg, which is known to interact with both Tax [13-15]
and CYLD [24,25]. The Tax/CYLD association was also
suggested by their colocalization in the cytoplasm of the
transfected cells (Figure 1C).
CYLD inhibits Tax ubiquitination
We next examined whether CYLD regulates the ubiquiti-
nation of Tax. As expected, Tax was constitutively ubiqui-
t i n a t e dw h e ne x p r e s s e di n2 9 3c e l l s( F i g u r e2 A ) .T h e
ubiquitin chains conjugated to Tax appeared to be predo-
minantly K63-linked, since a ubiquitin mutant lacking K63
(K63R) was defective in mediating Tax ubiquitination,
whereas the K48R ubiquitin mutant was competent in
mediating Tax ubiquitination (Figure 2B, lanes 1 and 2).
Furthermore, a ubiquitin mutant retaining lysine 63 but
none of the other lysines (K63) was able to mediate Tax
ubiquitination (Figure 2B, lane 4). Since CYLD is a DUB
that specifically deubiquitinates K63 ubiquitin chains
[21,24-26], we tested whether the ubiquitination of Tax
is subject to regulation by CYLD. Interestingly, the
ubiquitination of Tax was strongly inhibited when it was
coexpressed with CYLD (Figure 2C). The inhibitory effect
of CYLD on Tax ubiquitination was dependent on its
DUB catalytic activity, since a catalytically inactive CYLD
mutant failed to inhibit Tax ubiquitination (Figure 2C).
These data indicate that CYLD functions as a DUB that
negatively regulates Tax ubiquitination.
CYLD inhibits Tax-stimulated activation of IKK but not
that of Tak1
IKK activation by cellular signals is known to require the
MAP3K Tak1 [27-32]. Tak1-mediated phosphorylation
of IKKb, together with a ubiquitin-dependent mechan-
ism, regulate IKK activation by the TCR/CD28 signals
[33]. We have previously shown that Tax stimulates the
catalytic activity of both Tak1 and IKK [34], although the
underlying mechanism remains unclear. Since CYLD
deubiquitinates Tax, we examined the effect of CYLD on
these Tax-specific signaling events. When expressed in
293 cells, Tak1 displayed a low level of basal catalytic
activity as determined by in vitro kinase assay (Figure 3,
panel 1). As expected, the kinase activity of Tak1 was
potently stimulated by Tax, which was associated with
activation of its downstream kinase IKK (Figure 3, panels
1 and 3). Importantly, expression of wildtype CYLD, but
not its catalytically inactive mutant, strongly inhibited
Tax-stimulated activation of IKK (Figure 3, panel 3), sup-
porting a role for Tax ubiquitination in the activation of
I K Ks i g n a l i n g .H o w e v e r ,t oo u rs u r p r i s e ,C Y L Dd i dn o t
affect Tax-stimulated activation of Tak1. Thus, ubiquiti-
nation is differentially required for Tax-mediated activa-
tion of Tak1 and IKK. This finding is also consistent with
our previous observation that Tax-mediated Tak1 activa-
tion is required but not sufficient for IKK activation [34].
CYLD is constitutively phosphorylated in HTLV1-
transformed T cells
The catalytic activity of CYLD is negatively regulated by
its phosphorylation [22]. In response to cellular signals,
CYLD becomes transiently phosphorylated and inacti-
vated, thus contributing to the activation of IKK. Since
Tax stimulates persistent activation of IKK, we examined
the status of CYLD phosphorylation in a large panel of
T-cell lines transformed by HTLV1 or Tax. As expected,
the level of IBa (a primary target of IKK) was low in
these HTLV1-transformed T cell lines (Figure 4).
Remarkably, in all of these Tax-expressing cell lines,
CYLD was detected as two bands in IB assays (Figure 4).
As previously observed in mitogen-stimulated T cells, the
upper band represented the phosphorylated CYLD, since
it was converted to the basal form upon in vitro phospha-
tase treatment (Figure 4). Thus, CYLD undergoes consti-
tutive phosphorylation in HTLV1-transformed T cells.
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ubiquitination
To assess the role of CYLD phoshorylation in regulating
its catalytic activity, we examined the effect of a
phospho-mimetic CYLD mutant on Tax ubiquitination.
As expected, the wildtype CYLD, but not its catalytically
inactive mutant, efficiently inhibited Tax ubiquitination
( F i g u r e5 ,l a n e s2a n d3 ) .I m p o r t a n t l y ,ap h o s p h o -
Figure 1 Physical interaction between Tax and CYLD. (A) Cell lysates were prepared from the HTLV1-transformed C8166 cell line and
subjected to IP using either a control pre-immune serum or anti-CYLD. The precipitated CYLD and its associated Tax were analyzed by IB. (B)
HEK293 cells were transfected with HA-CYLD and Tax either in the absence (-) or presence (+) of IKKg. The cell lysates were subjected to IP using
anti-CYLD followed by IB to detect the precipitated CYLD and its associated Tax (top two panels). The cell lysates were also subjected to direct
IB to monitor the expression of IKKg and Tax. (C) HEK293 cells were transfected with HA-CYLD and Tax. The cells were stained with anti-HA (Y-
11) and a mouse monoclonal anti-Tax antibody, followed with Texas red-conjugated donkey anti-rabbit Ig and FITC-conjugated donkey anti-
mouse Ig. Cells were also counterstained with Hoechst 33258 for nuclear visualization. The expression of CYLD, Tax, Tax-CYLD merge, and
nucleus (Hoechst) are shown. Note that the cytoplasmic, but not nuclear, Tax was colocalized with CYLD (Tax-CYLD merge, yellow color).
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substitutions at the phosphorylation sites (CYLD7SE, see
ref. [22]) completely failed to deubiquitinate Tax (Figure
5, lane 5), whereas a mutant harboring serine to analine
mutations at the phsphorylation sites of CYLD
(CYLD7SA) remained active in Tax deubiquitination
(Figure 5, lane 4). Thus, in HTLV1-transformed T cells,
CYLD is inactivated via constitutive phosphorylation,
Figure 2 Tax undergoes K63 ubiquitination, which is inhibited by CYLD. (A) 293 cells were transfected with HA-tagged ubiquitin together
with vector control (V) or Tax. Protein lysates were subjected to IP using anti-Tax, and ubiquitin-conjugated Tax and Tax were detected by IB
with HRP-anti-HA and anti-Tax, respectively. (B) 293 cells were transfected with Tax together with the indicated ubiquitin mutants. Tax was
subject to IP and ubiquitination assays as in A (left panel). Cell lysates were analyzed by IB to monitor ubiquitin expression (right panels). K48R
and K63R harbor K/R substitutions at lysines 48 and 63, respectively. K48 and K63 harbor K/R substitutions in all lysines except 48 and 63,
respectively. (C) HEK293 cells were transfected with Tax and HA-tagged ubiquitin either the in the absence (-) or the presence of wildtype (WT)
CYLD or a catalytically inactive CYLD mutant (Mut). Cell lysates were subjected to Tax ubiquitination (left panel) and IB (right panel) assays. The
Tax expression level was comparable between the different lanes (data not shown).
Figure 3 CYLD inhibits Tax-stimulated activation of IKK but not that of Tak1. HEK293 cells were transfected with the indicated expression
vectors. Cell lysates were subjected to in vitro kinase assays to detect the activation of endogenous Tak1 (panel 1) and IKK (panel 3). Following
autoradiography, the kinase assay membranes were subjected to IB to detect the Tak1 (panel 2) and IKKb (panel 4) proteins. The expression level
of CYLD and Tax was monitored by IB (panels 5 and 6).
Wu et al. Cell & Bioscience 2011, 1:27
http://www.cellandbioscience.com/content/1/1/27
Page 4 of 8which may contribute to the aberrant activation of IKK
and NF-B.
Discussion
The data presented in this paper demonstrate a role for
CYLD in regulating the ubiquitination of Tax, oncopro-
tein of the leukemia virus HTLV1 [2]. CYLD is physi-
cally assembled into the Tax complex and involved in
negative regulation of Tax ubiquitination and signaling
function. Furthermore, Tax and CYLD appear to
mutually regulate, since CYLD is constitutively phos-
phorylated in HTLV1-transformed T cells.
Strong evidence suggests that Tax ubiquitination plays
ac r i t i c a lr o l ei ni t ss i g n a l i n gf u n c t i o ni nt h eN F - B
p a t h w a y[ 3 5 ] .I n d e e d ,w eh a v es h o w nt h a tC Y L D -
mediated Tax deubiquitination is associated with
attenuation of IKK activation. Similarly, the ubiquitina-
tion and function of Tax are also regulated by another
deubiquitinase, USP20 [36]. These findings suggest that
ubiquitinated Tax may be targeted by different deubi-
quitinases, although precisely how the different deubi-
quitinases regulate Tax during HTLV1 infection remains
to be further studied.
Our current study demonstrates that the CYLD-
mediated Tax deubiquitination did not affect Tax’sa b i l -
ity to activate Tak1. This finding suggests that Tak1
activation is insufficient for Tax-mediated IKK activa-
tion, implicating the involvement of different mechan-
isms in Tax activation of Tak1 and IKK. In further
support of this idea, our previous work demonstrates
that a Tax mutant, TaxM22, is capable of Tak1 activa-
tion despite its defect in IKK activation [34]. One possi-
bility is that Tax not only activates Tak1 but also
Figure 4 Constitutive phosphorylation of CYLD in HTLV1-transformed T cells. Whole-cell lysates were prepared from control Jurkat T cells
or the indicated Tax-expressing (Tax
+) T cell lines transformed by Tax (Tax1) or HTLV1 (C8166, SLB-1, E55, HUT102) and subjected to IB using
anti-CYLD (upper) or anti-IBa (lower). In lanes 7 and 8, the cell lysates were incubated in vitro with either buffer or calf intestinal phosphatase
(CIP) to show that the more slowly migrating protein band is phosphorylated CYLD.
Figure 5 A phospho-mimetic CYLD is defective in inhibiting
Tax ubiquitination. HEK293 cells were transfected with Tax and
HA-ubiquitin either in the absence (-) or presence of wildtype (WT)
CYLD, the catalytically inactive CYLD mutant (Mut), or CYLD mutants
harboring serine-to-alanine (SA) or serine-to-glutamic acids (SE)
substitutions at its phsophorylation sites. Cell lysates were subjected
to Tax ubiquitination (upper) or direct IB to analyze the expression
of ubiquitin, CYLD, and Tax (lower three panels).
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vation. Future studies will examine whether Tax ubiqui-
tination is required for recruiting Tak1 to IKK.
The catalytic activity of CYLD is negatively regulated by
its phosphorylation [22]. Cellular stimuli induce transient
phosphorylation of CYLD, which may contribute to the
optimal activation of IKK. A remarkable finding in the
present study is that CYLD is constitutively phosphory-
lated in a large panel of HTLV1-transformed T cells. Since
a phospho-mimetic CYLD mutant is defective in inhibiting
Tax ubiquitination, the CYLD phosphorylation may con-
tribute to the chronic activation of IKK and NF-Bi n
HTLV1-transformed T cells. We have previously shown
that induction of CYLD phosphorylation by TNF-a or
mitogens is mediated by the IKK complex [22]. However,
we found that in HEK293 cells, Tax was insufficient for
the induction of CYLD phosphorylation (data not shown).
This result could be due to the low expression level of
IKK components, particularly IKKg [37], although the pos-
sibility for involvement of additional signaling factors can-
not be excluded. Regarding the latter possibility, a recent
study suggests that CYLD phosphorylation can also be
mediated by the IKK-related kinase IKKε and contributes
to IKKε-induced tumorigenesis [38]. Whether IKKε is
involved in the CYLD phosphorylation in HTLV1-trnas-
formed T cells is yet to be investigated. It also remains to
be examined whether CYLD phosphorylation also contri-
butes to HTLV1-induced T-cell transformation. Neverthe-
less, our data suggest that CYLD phosphorylation is a
mechanism that mediates constitutive Tax ubiquitination
and signaling function in HTLV1-transformed T cells.
Conclusions
The results of this study demonstrate a role for the DUB
CYLD in the negative regulation of HTLV1 Tax protein.
CYLD inhibits Tax-stimulated IKK activation via deubi-
quitinating Tax, although the CYLD-mediated Tax deubi-
quitination does not affect Tax activation of Tak1. Our
data further suggest that HTLV1 has developed a mechan-
ism to override the negative-regulatory role of CYLD, and
this mechanism involves the induction of CYLD
phosphorylation.
Methods
Cell lines and transfection
Human embryonic kidney cell line 293, human leukemia
T-cell line Jurkat, and HTLV1-transformed human T-
cell lines were described prev i o u s l y[ 3 4 ] .T h eT a x 1c e l l
line is an IL-2-dependent human T-cell line immorta-
lized by HTLV1 Tax in the context of a herpes saimiri
vector [39]. For transient transfection, 293 cells were
seeded in 6-well plates and transfected using Lipofecta-
mine-2000 (Invitrogen).
Plasmid constructs, antibodies, and other reagents
pCMV4-Tax was kindly provided by Dr. Warner Greene
[40]. pcDNA-based expression vectors encoding HA-
tagged IKKg, Ubiquitin, CYLD, a catalytically inactive
CYLD mutant (CYLDmut) were as described [14,22,41].
CYLD SA is a phosphorylation-deficient mutant harboring
alanine substitutions of seven serine residues, and CYLD
SE is a phospho-mimetic CYLD mutant harboring serine
to glutamic acid substitutions [22]. Ubiquitin mutants K48
and K63 (provided by Dr. Zhijian Chen) carry lysine-to-
arginine substitutions in all lysine residues, except K48
and K63, respectively. Ubiquitin mutants K48R and K63R
harbor mutations in lysine 48 and 63, respectively. pCMV-
HA-Tak1 expression vector and anti-Tak1 antibody were
kindly provided by Drs. Kunihiro Matsumoto and Jun
Ninomiya-Tsuji [42]. All other reagents were described
previously [34].
Immunoblotting (IB), immunoprecipitation (IP), in vitro
kinase assay, and ubiquitination assay
Cell lysates were prepared by lysing the cells in RIPA buf-
fer for IB and IP [43]. For kinase assays, cells were lysed in
a kinase lysis buffer supplemented with phosphatase inhi-
bitors and immediately subject to in vitro kinase assays as
described previously [9]. For ubiquitination assays, cells
were transfected with HA-tagged ubiquitin or its mutants
along with other expression vectors. The cells were lysed
in RIPA buffer supplemented with 4 mM N-ethylmalei-
mide (NEM) and immediately bioled for 5 min in the pre-
sence of 1% SDS and then diluted 10 times with RIPA
buffer. Ubiquitinated Tax was isolated by IP using anti-
Tax and detected by IB with anti-HA.
Immunofluorescence assay
HEK293 cells were transiently transfected with HA-
CYLD and Tax and subjected to indirect immunofluor-
escence assays as described [18].
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